On October 5, the awarding ceremony of the Green Cross international pharmaceutical award took place. The professional distinction is awarded in 2018 for the fourth time, clearly showing with whom the pharmacy community vests its trust. Hundreds of companies and pharmaceutical brands competed for the victory in 56 nominations of 5 categories.
This year, Kagocel was recognized No. 1 in the nomination «Medication of choice for prophylaxis and treatment of ARVI and influenza». This is the second award for the distinction’s short existence received by the antiviral drug. A universal remedy for ARVI and influenza, Kagocel for a long time has been the choice of professionals, including doctors (as a many times winner of the Russian Pharma Awards).
The Green Cross expert council includes owners, directors, as well as leading managers of pharmacy chains, distributors, representatives of pharmaceutical and analytical companies, and other industry professionals. They determined the winners in a two-stage voting. In addition, the website of the award conducted an open vote for pharmacists and pharma chemists to make their choice. It is the vote of the expert community that granted Kagocel the opportunity to be once again recognized as a drug of choice, proving its leading position in the industry.